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procedures that use DES.
Figure 1: Predicted contribution margin reduction at a case study hospital (in 000s)
1040-75 Population Rates of Invasive Cardiac Procedures in 
British Columbia, 1995-2001
Gordon E. Pate, Karin H. Humphries, Mona Izadnegahdar, Min Gao, Michael Kiely, 
Ronald G. Carere, Saint Paul's Hospital, Vancouver, BC, Canada, Centre for Health 
Evaluation and Outcomes Sciences, Vancouver, BC, Canada
Background: This audit examined the age-sex standardized population rates of coronary
angiography (CA), percutaneous intervention (PCI) and coronary artery bypass surgery
(CABG) in British Columbia (BC) between 1995 and 2001.
Methods: Data sources were as follows: CABG-BC Cardiac Registry, CA and PCI- BC
Medical Services Plan, Acute Coronary Syndromes (ACS, ICD9 codes 410,411,413)-
Hospital Separation database,population data-BC Statistics. All rates are age and sex
standardized per 100,000 BC resident adults over 20 years.
Results: The rates of diagnostic CA and PCI have increased from 352 and 101 per
100,000 in 1995 to 400 and 154 per 100,000 respectively in 2001 (p<0.01). Single stage
‘ad hoc’ PCI increased from 38% in 1995 to 68% in 2001. The stenting rate increased
dramatically from 25% of PCI procedures in 1995 to 90% in 2001 (p<0.01). The rate of
CABG remained stable at between 70-79 per 100,000. There was a downward trend in
the annual hospitalized incidence of ACS (477 to 430, p=0.04). The incidence of ACS
and the rates of CA, PCI and CABG were higher for men in all age groups. PCI was more
common than CABG in all groups.
Conclusion: The incidence of ACS in British Columbia is falling. The rates of SCA and
PCI are increasing. This may reflect an appropriate evidence-based response to data
supporting greater application of coronary angiography following acute coronary syn-
dromes after publication of several studies supporting a routine invasive approach.
Table:
1040-76 30-Day Mortality Trends Following Acute Myocardial 
Infarction in the Elderly
Judith H. Lichtman, Yun Wang, Sharon-Lise Normand, Rhuna Shen, Lawrence M. Brass, 
Harlan M. Krumholz, Yale University School of Medicine, New Haven, CT
Background. Despite numerous innovations in prevention, diagnosis and treatment of
acute myocardial infarction (AMI), relatively little is known about how these changes have
modified short-term mortality outcomes over time, especially for elderly patients. Current
estimates have generally been derived from small geographic areas, or voluntary regis-
tries that may not be generalizable beyond participating locations or institutions. We
sought to examine national 30- day mortality trends following an AMI among elderly
Medicare beneficiaries (benes).
Methods. All fee-for-service (FFS) Medicare benes 65 years of age or older, discharged
with an AMI (ICD-9 410.xx) from 1993-1999 were included in the study. AMI patients dis-
charged from non-acute facilities, transfers, repeat admissions within 8 weeks, or those
with less than 12 months of continuous FFS status were excluded. Risk adjustment vari-
ables included demographics, and comorbidities and cardiac procedures identified from
hospitalizations within the prior year. Observed and expected 30-day mortality rates were
calculated for age (65-74, 75-84, 85+) and gender subgroups. Logistic regression models
compared annual mortality rates relative to 1993, with adjustment for demographic and
clinical factors.
Results. There were a total of 1,814,196 AMI discharges from 1993-1999. Annual unad-
justed mortality rates remained stable over time (range of 19-20%), despite trends of
increasing comorbidities, cardiac procedures, and advancing mean age of the AMI benes
over the time period. Women had a modest decline in mortality within all age groups, but
rates for men remained relatively stable, with a slight increase for men 85+ years of age.
Risk adjusted annual mortality rates remained essentially unchanged over time (OR
1.01, 95% CI 1.00-1.03; 1.03, 1.01-1.04; 1.01, 0.99-1.02; 0.99, 0.97-1.00; 0.98, 0.97-
1.00; and 1.01; 1.00-1.03).
Conclusions. Despite minor decreases in mortality for women within all age groups, the
absolute decreases in mortality rates are negligible. It is unclear whether the static rates
signal limitations of current therapeutic options, the increasing complexity of AMI
patients, or a combination of these factors.
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1058-67 Durability of Bioprosthetic Aortic Valves: What Is the 
Re-Operation Risk for My Patients?
John Puvimanasinghe, Johanna Takkenberg, Marinus Eijkemans, Ewout Steyerberg, Lex 
van Herwerden, Eric Jamieson, Gary Grunkemeier, Dik Habbema, Ad Bogers, Erasmus 
Medical Center, Rotterdam, The Netherlands, Providence Health System, Portland, OR
Background: A drawback to the choice of bioprostheses for aortic valve replacement
(AVR) is their limited durability and resultant need for re-operation. The purpose of this
study was to quantify and compare structural valvular deterioration (SVD), re-operation-
free life expectancy and the lifetime risk of re-operation after aortic valve replacement
with three widely used bioprostheses respectively.
Methods: We used long-term follow-up data on Carpentier-Edwards standard porcine
(CE-S), Carpentier-Edwards bovine pericardial (CE-P) and Carpentier-Edwards supra-
annular porcine (CE-SA) bioprostheses to generate age-dependent Weibull curves to
describe SVD. These curves were used to calculate the median time to SVD at different
patient ages of implantation. We also conducted a meta-analysis of the literature (CE-S –
3,161 patients and 22,326 patient-years; CE-P – 2,685 patients and 12,250 patient-
years; CE-SA – 3,796 patients and 20,127 patient-years) to estimate the hazards of other
valve-related events. The results of the Weibull analysis and meta-analysis were used to
parameterize a micro-simulation model, which calculated the re-operation-free life
expectancy and lifetime risk of SVD in these patients.
Results: For example, for a 65-year-old male, median time to SVD was 15.3, 20.1 and
22.2 years for the CE-S, CE-P and CE-SA valves. Re-operation-free life expectancy was
9.3, 9.9 and 10.1 years and the lifetime risk of re-operation due to SVD was 31%, 17%
and 14% respectively. For a 70-year-old male, this lifetime risk of re-operation due to
SVD was 20%, 10% and 8% respectively.
Conclusions: Estimates of SVD in the second-generation pericardial and supra-annular
bioprostheses are comparable and provide an advantage over the first-generation stan-
dard valve. Both second-generation bioprostheses offer a low lifetime risk of re-operation
for elderly patients requiring aortic valve replacement. Microsimulation provides detailed
insight into the prognosis after AVR and assists in the choice of a valve for a given
patient.
1058-68 A Virtual Heart Model for Image Orientation and 
Teaching Three-Dimensional Echocardiography
Nico Bruining, Gernoth Grunst, Thomas Berlage, Bernhard Mumm, Johannes Waldinger, 
Jos R. Roelandt, Erasmus MC, Rotterdam, The Netherlands, GMD, Sankt_Augustin, 
Germany
The interest and clinical applications of three-dimensional echocardiography (3DE) is
rapidly growing. While initially used as a research tool, real-time 3DE is currently imple-
mented in state-of-the-art ultrasound consoles. However, most echocardiographers are
familiar with two-dimensional imaging and real-time 3D volume rendered images of car-
diac pathologies often pose difficulties in understanding both the origin and orientation of
the reconstructed tomographic views used for analysis. This phenomenon is referred to
as “lost in space”. We developed a virtual reality heart (VR) model and a demonstrator,
which can be linked to 3DE data sets, using three specific anatomical landmarks, provid-
ing spatial information and the geometric position of the heart within the 3DE data. The
demonstrator, which consists out of a dummy thorax, a space locator system and a data-
base that can be filled with 3DE data sets of cardiac pathologies, is used for virtual
echocardiographic patient examinations (fig.).We examined the usefulness of the VR
heart model integrated in commercially available 3D reconstruction and analytic software
(TomTec, Munich, Germany) in 61 3DE data sets obtained in 58 patients (24 transesoph-
ageal and 37 transthoracic examinations). In 70.3% of the cases the VR heart model was
linked to the 3DE data sets and successfully implemented in 3D reconstruction software
Age-sex standardized rates per 100,000 BC residents
1995 1996 1997 1998 1999 2000 2001
Acute Coronary Syndromes 477 484 434 442 440 430
Coronary Angiography 352 354 352 356 368 393 400
Percutaneous Coronary 
Intervention
101 108 113 122 131 144 154
Coronary Artery Bypass 
Grafting
73 75 76 79 77 75 70








for orientation and guiding. The demonstrator provides an excellent training tool to
become acquainted with echocardiography.
1058-69 Modeling and Prediction of Acute Hemodynamic Effects 
of an Arterial Assist Device
Salvatore A. Chiaramida, Naveen L. Pereira, Michael R. Zile, Christopher D. Nielsen, 
Adrian B. VanBakel, Donna M. Meyer, Ying Sun, Medical University of South Carolina, 
Charleston, SC, University of Rhode Island, Kingston, RI
Background: The concept of utilizing an arterial assist device in the form of a femoral-aor-
tic flow pump has been proposed to be of benefit in patients with severe refractory con-
gestive heart failure by reducing afterload and is currently under investigation.
Mechanisms for putative improved hemodynamics as suggested in preliminary studies
are not well understood. Method: A previously validated computer model is used to simu-
late hemodynamics and acute effects of the assist pump. The pump is modeled as a con-
stant flow source (Qp) from femoral artery to proximal descending aorta. The pressure
head loss in the descending aorta due to outflow velocity (V) is modeled by use of the
Bernoulli's equation: (dVV/2)(Qp/CO), where d is density of blood and CO is the intrinsic
cardiac output. Result: The control was set for congestive heart failure with hemody-
namic indices defined and shown in figure. The model maintained constant preload and
intrinsic myocardial contractility, and did not include effects due to change in coronary
perfusion. The percent changes of these indices were plotted as Qp varied from 0.2 to 2
L/min. Conclusion: Based on our computer simulation, superimposing an additional con-
stant flow on pulsatile aortic flow produces moderate improvement of hemodynamic indi-
ces in the proposed operant range of pump flow (1.2-1.5 L/min). A variety of system
parameters could shift this range. Observed increase in renal blood flow and secondary
neurohumoral actions could yield additional hemodynamic benefit. 
1058-70 Changes in Left Ventricular Activation Sequence in a 
Finite Element Model of Single Site Right Ventricular 
and Dual Site Biventricular Pacing
Frederick J. Vetter, Haiyan Sui, Salvatore A. Chiaramida, University of Rhode Island, 
Kingston, RI, Medical University of South Carolina, Charleston, SC
Background: Dual site biventricular pacing, where the left ventricle (LV) is paced with the
right ventricle (RV), improves outcome in some heart failure patients. Single site RV pac-
ing may lead to worse outcomes than dual site pacing, which may be related to asynchro-
nous LV activation. Methods: A two-dimensional finite element model of a realistic
ventricular geometry was used to compute changes in the LV activation sequence using
single site RV pacing and dual site biventricular pacing protocols. The RV protocol acti-
vated apical cavity nodes to simulate an endocardial lead stimulus. The dual site protocol
added a lead in the coronary sinus vein by activating nodes at the base of the LV free
wall. The cable equation, governing the spread of excitation, was solved in each case to
obtain the activation time of the propagated wave. Results: The upper midventricle of the
LV free wall was activated 67% earlier with dual site pacing relative to RV pacing; the
entire free wall was activated 55% earlier. Dual site pacing showed the activation
sequence reversal observed in patients benefiting from biventricular pacing, and more
closely resembles normal activation by reducing LV activation asynchrony. Conclusion:
Realistic simulations showed markedly different LV free wall activation between single
site RV and dual site pacing. This tool is useful to investigate how altered activation
enhances cardiac output and improves outcome, and may suggest new beneficial pacing
strategies. Supported by NCRR-NIH Grant P20 RR 16457.
1058-71 Visualization of the Effect of Atrial-Ventricular and 
Right-Left Delay on Cardiac Output During Biventricular 
Pacing
T. Alexander Quinn, David G. Rabkin, Santos E. Cabreriza, Lauren J. Curtis, Henry M. 
Spotnitz, Columbia University, New York, NY
Background: Biventricular pacing (BiVP) has great potential as an adjunctive treatment
for patients with acute and chronic heart failure. Acute optimization of BiVP requires
determining the appropriate atrial-ventricular delay (AVD) and right-left delay (RLD) on a
patient-to-patient basis. Presently there is no good method for optimization of AVD and
RLD in BiVP for improved cardiac output (CO), so we therefore examined the utility of CO
surface plots for optimization of BiVP.
Methods: In a study of pulmonary stenosis and tricuspid insufficiency in anesthetized
pigs with induced heart block, AVD and RLD were varied during BiVP and CO measured
using an ultrasonic flow probe. Surface plots displaying CO with variations in AVD and
RLD were generated. CO, represented by a red-to-blue color map (the vertical bar), is
plotted against varying AVD (60 to 180 msec) on the ordinate and RLD (80 to –80 msec)
on the abscissa and linearly interpolated between measured values.
Results: The figure below shows representative CO surface plots during BiVP in a pig
with pulmonary stenosis (left) and tricuspid insufficiency (right). (Note: Here the color
spectrum is displayed as a gray scale map, with black representing the highest CO). The
plots show the optimal settings of AVD and RLD, indicated by the darkest area of the sur-
face.
Conclusion: CO surface plots allow visualization of the effects of AVD and RLD on CO
during BiVP. By use of emerging technologies, CO maps may be useful for determining
the optimal AVD and RLD settings for BiVP. 
1058-72 Computer Model of the Human Atrium as a Study Tool 
for Atrial Arrhythmias
Carin Siegerman, Marta Vakulenko, Zenaida Feliciano, Alan Garfinkel, UCLA School of 
Medicine, Los Angeles, CA
Background: Atrial fibrillation (AF) affects 5% of people older than 60 years of age. The
design of a successful strategy against AF depends on an understanding of the funda-
mental mechanisms creating this arrhythmia. An accurate anatomic and electrophysio-
logic model of the normal atrium is an essential experimental system for the study of AF.
Methods: Our model of the normal human atrium includes fast conducting regions (pec-
tinate muscles, the crista terminalis, superior and inferior interatrial connections), slow
conducting regions (isthmus, limbus of fossa ovalis), and the pulmonary veins (Figure). It
uses a model of the atrial myocyte that accurately reproduces the human transmem-
brane potential and the effective refractory period (ERP). Pacing simulations in this
model were used to evaluate how closely our model resembles the known human atrial
behavior.
Results: The accuracy of the interatrial connections results in simulations of atrial depo-
larization and refractoriness (ERP ~235 ms) that closely resembles those reported for
the human atrium. AF can be induced in this model by cross-field stimulation; this AF is
self-terminating, as is also seen in real human atrium.
Conclusion: A mathematical model of the human atrium that resembles human atrial
physiology has been developed and may prove to be an indispensable research tool for
the study of atrial arrhythmias. 
